Low-Dose Methotrexate Can Cause Adverse Effects

NEW YORK (Reuters Health)—Low-dose methotrexate can be associated with gastrointestinal, pulmonary, infectious, hematologic and other adverse effects, according to an analysis of the Cardiovascular Inflammation Reduction Trial (CIRT). “Methotrexate is not a benign drug, even at dosages used for rheumatic diseases,” Daniel H. Solomon, MD, MPH of Brigham and Women’s Hospital, Boston, tells Reuters Health... [Read More]

Source: The Rheumatologist - February 19, 2020 Category: Rheumatology Authors: Will Boggs, MD Tags: DMARDs & Immunosuppressives Drug Updates adverse events Methotrexate Source Type: research